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Background: Free perforation is the most severe and debilitating complication associated with Crohn’s disease
(CD), and it usually requires emergency surgery. The aim of this study was to evaluate the incidence of free
perforation among Korean patients with CD.
Methods: The CrOhn's disease cliNical NEtwork and CohorT (CONNECT) study was conducted nationwide in Korea,
and patients who were diagnosed with CD between 1982 and 2008 were included in this retrospective study. We
investigated the incidence of free perforation among these patients and their clinical characteristics.
Results: A total of 1346 patients were analyzed and 88 patients (6.5%) were identified with free perforation in CD.
The mean age of the free perforation group was 31.8 ± 13.0 years, which was significantly higher than that of the
non-perforated group (27.5 ± 12.1 years) (p = 0.004). Free perforation was the presenting sign of CD in 46 patients
(52%). Of the 94 perforations that were present in 88 patients, 81 involved the ileum. Multivariate logistic regression
analysis determined that free perforation was significantly associated with being aged ≥ 30 years at diagnosis (OR
2.082, p = 0.002) and bowel strictures (OR 1.982, p = 0.004). The mortality rate in the free perforation group was
significantly higher (4.5%) than that in the non-perforated group (0.6%) (p < 0.001).
Conclusion: The incidence of free perforation in Korean patients with CD was 6.5%. Being aged≥ 30 years at CD
diagnosis and bowel strictures were significant risk factors associated with free perforation.
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Crohn’s disease (CD) is a chronic and relapsing inflam-
matory bowel disease (IBD) that can affect the entire
gastrointestinal (GI) tract. The early and accurate diag-
nosis of CD can be challenging, particularly in patients
in whom there is mild clinical activity that mimics symp-
toms associated with functional GI disorders [1].
Free perforation is relatively rare among the major
complications of CD that include stenoses, fistulae and
perforations. However, free perforation is the most se-
vere and debilitating complication, and it usually re-
quires emergency surgery. While the incidence of CD* Correspondence: yousunk69@korea.com
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unless otherwise stated.remains lower than that in western countries, the recent
increases in its incidence in Asian countries are remark-
able [2,3]. The characteristics of CD have been found to
differ between western countries and Asian countries
with respect to its prevalence between gender, the loca-
tions of the involved segments, and the frequencies of
GI complications [2,4-7]. A higher incidence of free per-
foration has been reported in Japan (6.8%) [8] compared
with western countries (1–3%) [9-13]. However, no
large-scale studies have been conducted to investigate
free perforation in patients with CD in Korea. The aim
of this study is to determine the incidence of free perfor-
ation, the clinical characteristics of CD patients with free
perforation, and the risk factors associated with free per-
foration in patients with CD in Korea.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Study population
A total of 1382 patients who had been diagnosed with
CD between July 1982 and December 2008 were in-
cluded in this retrospective cohort of the CrOhn's dis-
ease cliNical NEtwork and CohorT (CONNECT) study
[14]. Although the CONNECT study could not include
all CD patients in Korea, however, 34 institutes were
participated in this nationwide cohort study, therefore,
we suggested that the CONNECT study could be repre-
sentative of the Korean CD population. We conducted a
comparative study between patients with free perforation
and those without free perforation. The study was ap-
proved by the Institutional Ethics Review Board of Seoul
Paik Hospital.
Disease diagnosis and classifications
CD was diagnosed according to the diagnostic guidelines
for CD in Korea [15]. The diagnoses were systematically
re-evaluated before the patients were enrolled in the
study and they were confirmed at the end of the study.
The final diagnoses were documented in accordance
with the disease phenotypes within the Montreal classifi-
cation [16].
Spontaneous free perforation
Free perforation in CD was defined as a spontaneous per-
foration of the small or large bowel accompanied by the
flow of the intestinal contents into the peritoneal cavity.
We excluded abscess ruptures and secondary perforations
that were attributable to other primary lesions and were
identified from the patients’ surgical and medical records.
Clinical characteristics of the patients with free
perforation and its incidence
We examined the clinical characteristics of the patients
with free perforation in CD, including the time of symptom
onset, the year of diagnosis, the therapeutic drug history,
and the Montreal classification. We also investigated the
anatomical areas in which free perforation occurred and
the risk factors associated with free perforation in patients
with CD. To evaluate the clinical outcome, we compared
the groups in relation to GI complications that often re-
quire surgery, hospitalizations, and result in mortality.
Statistical analysis
The continuous variables are described as the medians and
the standard deviations (SD), and the categorical variables
are presented as proportions and percentages. The differ-
ences between the groups were assessed using the χ2 test
for categorical variables and independent t-test for con-
tinuous variables. Multivariate logistic regression analysis
was used to examine the associations between the clinical
characteristics of the patients and free perforation inpatients with CD. Relative risk (RR) was used to evaluate
the mortality rate of patients with free perforation. The
data were analyzed using PASW Statistics for Windows,
Version 18.0 (IBM Corporation, Armonk, NY, USA).Results
Incidence of free perforation
A total of 124 patients were recorded as having any type of
perforation associated with CD. Of these, 14 patients were
excluded from the study, because thorough evaluations of
their clinical and surgical findings determined that their
perforations did not satisfy the definition of spontaneous
free perforation (8 patients had abscess ruptures, 2 patients
had fistulae that mimicked perforations, 2 patients had
peptic ulcer perforations, 1 patient had a perforation
caused by colonoscopy, and 1 patient had a perforation
that was secondary to a GI malignancy). In addition, 22 pa-
tients who had suspected but not confirmed free perfora-
tions, according to their surgical records, were excluded
from the study. Hence, of 1346 patients, 88 (6.5%) were
identified with free perforation in CD. Among the 88 pa-
tients with free perforation, it was the presenting sign that
was associated with a diagnosis of CD in 46 patients (52%),
and free perforation developed after the diagnosis of CD in
42 patients (48%).Clinical characteristics of CD patients with free
perforation
We divided the patients with CD into the free perforation
group (n = 88) and the non-perforated group (n = 1258).
The mean follow-up periods were 125.9 ± 64.4 months for
the free perforation group and 103.7 ± 50.9 months for the
non-perforated group. The mean age of the patients in the
free perforation group was 31.8 ± 13.0 years, and this was
significantly higher than that in the non-perforated group,
which was 27.5 ± 12.1 years (p = 0.004).
The median time interval between the first symptom and
a diagnosis of CD was 5.1 (0–276.6) months in the free per-
foration group and 3.5 (0–412.4) months in non-perforated
group, a difference that was not significant (p = 0.074).
The location of the disease at diagnosis showed signifi-
cant differences between the groups, and small bowel
involvement was found more frequently in the free perfor-
ation group (p = 0.032). Of the 94 perforations that were
present in 88 patients, 81 (86.2%) involved the ileum, 6
(6.4%) involved the jejunum, and 7 (7.9%) involved the
colon, and 5 patients had perforations at multiple sites (3
patients had perforations in the colon and ileum, 1 patient
had perforations in the jejunum and ileum, and 1 patient
had 3 perforations in the ileum). Surgery was performed
on all of the patients, and it comprised 1 primary repair
and 93 segmental resections. We did not identify any mor-
tality that was attributable to the surgery. Table 1 shows
Table 1 Comparison of characteristics between free perforation group and non-perforated group in patients with
Crohn’s disease
Patients with free
perforation (n = 88)
Patients without free
perforation (n = 1258)
P-value
Gender (female) 22 (25.0) 380 (29.4) 0.355
Age at diagnosis with CD (years) 31.8 ± 13.0 27.5 ± 12.1 0.004
Age at diagnosis ≥30 yr (%) 39 (44.3) 370 (29.4) 0.003
Time from the first symptom to diagnosis (months)* 5.1 (0–276.6) 3.5 (0–412.4) 0.074
Smoking history 15 (17.0) 189 (15.1) 0.640
Family history of IBD 1 (1.1) 31 (2.5) 0.461
CDAI at diagnosis with CD* 161 (30–450) 175 (3–585) 0.658
Disease Location at diagnosis with CD
L1 (Terminal ileum) ± L4 25 (28.4) 251 (19.4) 0.032
L2 (Colon) ± L4 6 (6.8) 147 (11.4) 0.176
L3 (Ileocolon) ± L4 55 (62.5) 852 (67.7) 0.482
Disease behavior at diagnosis with CD
Inflammatory (B1) 36 (40.9) 1060 (84.3) <0.001
Stricturing (B2) 6 (6.8) 123 (9.5) 0.350
Penetrating (B3) 46 (52.3) 75 (5.8) <0.001
Intestinal complications during whole disease period
Bowel stricture 36 (40.9) 318 (25.7) 0.001
Perianal fistula 26 (29.5) 471 (37.5) 0.138
Other fistula 20 (22.7) 184 (14.7) 0.040
Intra-abdominal Abscess 21 (23.9) 148 (11.8) 0.001
Number of CD related hospitalization 4.9 ± 7.2 2.9 ± 4.4 0.020
Mortality 4 (4.5) 8 (0.6) <0.001
Data are expressed as n (%) or mean ± SD or median (range)*.
CD, Crohn’s disease.
IBD, Inflammatory bowel disease.
CDAI, Crohn’s disease activity index.
Table 2 Multivariate logistic regression analysis for risk
factors of free perforation in patients with Crohn’s
disease
Parameter OR 95% CI P-value
Age at diagnosis≥ 30 yr 2.082 1.311-3.307 0.002
Bowel stricture 1.982 1.243-3.160 0.004
L1 (Terminal ileum) ± L4 1.532 0.916-2.562 0.194
Other fistula 1.414 0.767-2.608 0.268
Intra-abdominal Abscess 1.713 0.906-3.239 0.098
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group and non-perforated group in our CD cohort.
Risk factors associated with free perforation
Univariate analysis of the factors associated with free per-
foration showed that bowel strictures were significantly
more frequent in the free perforation group compared with
the non-perforated group (40.9% vs. 25.7%, p = 0.001).
Significant differences were apparent between the free per-
foration group and the non-perforated group in relation
to the frequencies of other fistulae (22.7% vs. 14.7%,
p = 0.040) and intra-abdominal abscesses (23.9% vs. 11.8%,
p = 0.001), but the frequency of perianal fistulae did not
differ between the groups (Table 1).
Multivariate logistic regression analysis determined
that free perforation was significantly associated with be-
ing over 30 years of age when CD was diagnosed (odds
ratio [OR] 2.082, 95% confidence interval [CI] 1.311–
3.307, p = 0.002) and having bowel strictures (OR 1.982,
95% CI 1.243–3.160, p = 0.004). However, the location ofthe disease in the ileum (p = 0.194), the presence of
other fistulae (p = 0.268), and the presence of intra-
abdominal abscesses (p = 0.098) were not significantly
associated with free perforation (Table 2).
Prognosis of CD patients with free perforation
Twelve patients died during the study, and the mortality
of the perforation group (4.6%, 4/88) was significantly
higher compared with that of the non-perforated group
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Eight deaths were attributed to CD, with 3/88 patients
(3.4%) died in the perforation group and 5/1258 patients
(0.39%) died in the non-perforated group.
Discussion
It is difficult to accurately determine the incidence of
free perforation because of its rarity. The CONNECT
retrospective cohort study has enabled us to report that
the incidence of free perforation among Korean patients
who were diagnosed with CD between 1982 and 2008 is
relatively high at 6.5% compared with the incidence of
1–3% in western countries [9-13]. However, our result is
similar to the incidence of free perforation in Japanese
patients with CD that was reported from a Japanese
meta-analysis (6.8%) [8]. To the best of our knowledge,
this is the first report of the incidence of free perforation
in patients with CD using data from a large-scale multi-
center cohort study undertaken in East Asia.
It is widely accepted that the IBD phenotypes differ
between Asian and Caucasian populations [2,4,5,14].
With regard to the location of free perforation, Green-
stein et al. reported that 50.0% of perforations occur in
the ileum and 50.0% of perforations occur in the colon
[11]. However, in our study we found that ileal perfora-
tions had a dramatically higher incidence (86.2%) and
that colonic perforations occurred in only 7.4% of the
patients. The Japanese study also reported that 80.0% of
perforations occur in the ileum, which is similar to our
results [8]. These findings may reflect the different char-
acteristics of these patients and the fact that involvement
of the small bowel is more frequent in Asia [4]. Al-
though multivariate logistic regression analysis did not
determine an association between the location of the
disease in the ileum and free perforation, we think that
the perforation risk might be associated with diagnostic
difficulties that relate to the location of the initial lesion.
Multivariate logistic regression analysis determined
that being over 30 years of age when CD was diagnosed
was significantly associated with free perforation (OR
2.082, p = 0.002). In the current study cohort, the mean
age at which CD was diagnosed was 31.8 years in the
free perforation group. These results had led us to con-
sider that the high rate of free perforation in our study
might be attributable to diagnostic delays and subse-
quent treatment delays, which can lead to poor progno-
ses [1,17,18]. This concept is supported by the finding
that the time interval between symptom onset and diag-
nosis was a little longer in the perforation group com-
pared with the non-perforated group, but this difference
was not statistically significant (p = 0.074). In addition,
free perforation was the presenting sign that was associ-
ated with a diagnosis of CD in 52% of the patients in the
perforation group, while it has been reported as 23–30%in other studies [11]. We consider that the high propor-
tion of free perforation as the presenting sign of CD is
indicative of failures to achieve early diagnoses of CD
that resulted in an increase in the perforation rate
among patients with CD.
Reports from previous studies have suggested that ste-
roids increase the risk of free perforation by obscuring
clinical signs and by preventing the closure of perfora-
tions [9-12,19-21]. Some studies have reported that anti-
tumor necrosis factor (TNF) agents are risk factors for
free perforation [22,23]. However, our analysis could not
accurately determine the influence of anti-TNF agents,
because many of the patients with free perforation were
diagnosed before infliximab had been introduced into
clinical practice in Korea. Recently, Korean retrospective
study including 721 subjects reported that the cumula-
tive probabilities of operation (P = 0.905) and reopera-
tion (P = 0.418) showed no differences between the two
groups which divided by the introduction of biologic
agents (two groups depending on the date of CD diagno-
sis; 1987 to 2005 vs. 2006 to 2012) [24]. The authors of
this study suggested that a considerable proportion
(36.8%) of the second group may have been given anti-
TNF agents only after developing a significant level of
bowel damage. Therefore, a further prospective study
with “early use of biologic agents” would be needed to
assess accurately the influence of anti-TNF agents on
free perforation [25].
The exact mechanism that underlies free perforation
in CD is unknown, but 2 hypotheses have been pro-
posed. The first and most plausible hypothesis suggests
that an increase in the intraluminal pressure proximal to
a stenosis causes a bowel distension to perforate the thin
layer overlying a deep ulcer [8-12,21,26]. In this study,
we identified that bowel strictures are an independent
risk factor associated with free perforation (OR 1.982,
p = 0.004). The second hypothesis suggests that in some
patients who do not have dilatations and strictures,
bowel ischemia may be attributed to the inflammation of
the small vessels [27]. We could not investigate the his-
topathologic findings in detail nor could we evaluate
bowel ischemia in the current retrospective study.
In addition to bowel strictures, complications such as
fistulae and intra-abdominal abscesses, developed fre-
quently and hospitalizations were more frequent in the
perforation group. The mortality rate was higher in the
free perforation group (4.5%) compared with the non-
perforated group (0.6%) (RR = 7.72, p < 0.001). Given
that there were no deaths from surgical complications,
we considered that perforation might be indicative of a
poor prognosis, because it is an acute and severe com-
plication that requires emergency surgery, and it is an
integral part of the natural course of the disease. Similis
et al. similarly reported a higher rate of operative
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compared with those who did not have perforations
[28]. However, with improvement in surgical procedures
[29-31] and the availability of newer medication includ-
ing biologics, this may lead to the successful treatment
of patients [32].
This study is limited by its retrospective design. First,
some of the surgical records did not contain complete de-
scriptions of the patients. Second, we could not accurately
evaluate the effects of the medications on the perforations
or the complications associated with the perforations, be-
cause the dates on which the medications were initiated
and the timings of the onset of complications were not ac-
curately recorded. We suggest that future studies should
be undertaken that use data from a prospective cohort of
the CONNECT study [14].
Conclusion
The incidence of free perforation in Korean patients with
CD was 6.5%, and this is higher than the incidence in west-
ern countries, which reflects the specific phenotype of
Asian patients with CD. The diagnosis of CD at an older
age (≥ 30 years) and bowel strictures were significant risk
factors associated with free perforation.
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